A gene, CmCDR1, encoding an ABC transporter of the dicarboxylic acid (DCA)-producing yeast Candida maltosa was cloned. Transcription of CmCDR1 was upregulated in a DCA-hyper-producing mutant of C. maltosa in a later phase of culture on n-dodecane, but not in its parental strain. CmCDR1 expression was significantly induced by the longer-chain DCA in this mutant.
In n-alkane-assimilating yeasts, n-alkanes are hydroxylated to fatty alcohols in the endoplasmic reticulum (ER) membrane by cytochromes P450ALK belonging to the CYP52 family. [3] [4] [5] [6] [7] [8] [9] [10] Fatty alcohols are sequentially oxidized to fatty acids, which are used in the synthesis of membrane or storage lipids or are degraded by -oxidation in the peroxisome. n-Alkanes and/or fatty acids are also !-hydroxylated by certain P450ALKs with !-hydroxylation activities and converted to DCAs. 11) To improve the productivity of DCAs from n-alkanes, it is necessary to reduce fatty acid consumption through -oxidation. Indeed, DCA-hyperproducing mutant M2030 exhibited reduced protein levels of acyl-CoA oxidase and 3-ketoacyl-CoA thiolase, which are involved in the -oxidation of fatty acids, as compared to the parental strain. 12) In addition, proliferation of peroxisomes, where fatty acid -oxidation occurs, was scarcely observed in the M2030 strain cultured on n-alkane.
For higher productivity of DCA, it is assumed that the intracellular DCA concentration must be kept at a low level, since DCA accumulation can be toxic to cells and since DCA production can be decreased by product inhibition or feedback regulation caused by accumulated DCA. Thus it is possible that a DCAhyper-producing mutant can excrete DCA efficiently into the culture medium. In addition, further enhancement of the DCA excretion ability by genetic engineering might lead to improvements in DCA productivity. ABC transporters are widely conserved membrane proteins containing two highly conserved nucleotidebinding domains (NBDs). They function in the efflux of a wide variety of hydrophobic compounds in various organisms, including yeasts. 13, 14) In the present study, we isolated a gene encoding an ABC transporter of C. maltosa and analyzed its expression in a DCA-hyperproducing mutant.
In the NBDs of ABC transporters, the Walker A, Walker B, and ABC signature motifs, which are important for the hydrolysis of ATP, are well conserved. 15) From the amino acid sequences of these motifs and the surrounding regions of yeast ABC transporters, Cdr1p to Cdr4p of Candida albicans, [16] [17] [18] [19] and Snq2p, Pdr5p, and Pdr12p of Saccharomyces cerevisiae, [20] [21] [22] we designed degenerate primers 5 0 -TGYTCNACHTT-NTTRAARAC-3 0 and 5 0 -CKYTTWCKYTCHCCHCC-DGA-3 0 , taking the codon usage of C. maltosa into consideration. We amplified DNA fragments with these primers by PCR from the total DNA of wild-type C. maltosa strain IAM12247. We obtained two 353-bp DNA fragments, 5-1 and 5-2, the deduced amino acid sequences of which exhibited 88% identity to that of C. albicans Cdr1p and 81% identity to that of C. albicans Cdr4p respectively. With DNA fragment 5-1 as probe, a DNA fragment was obtained from a genomic DNA library of the C. maltosa IAM12247 strain by colony hybridization by means of the ECL Direct Nucleic Acid Labeling and Detection System (GE Healthcare). The nucleotide sequence of this clone contains part of the coding region of a protein highly homologous to C. albicans Note 5 0 -GAGATGAATGTAAACCAACTG-3 0 , a DNA fragment was obtained that contained the rest of the coding region and the 3 0 -non-coding region. We determined the 6,133-bp nucleotide sequence of both fragments, and found an open reading frame (ORF) of 4,503 bp that encoded a 1,500 amino acid protein, which exhibited 83%, 84%, and 83% identity to the Cdr1ps of C. albicans, Candida dubliniensis, and Candida tropicalis respectively (DDBJ accession no. AB830574). Cdr1p of C. albicans is involved in cycloheximide resistance.
23) The amino acid sequences of Walker A motifs, Q-loops, ABC signature motifs, Walker B motifs, and H-loops in the two putative NBDs are completely conserved. 13, 14) We named this gene CmCDR1. Next we analyzed the expression of CmCDR1 in the mutant M2030 and parental strain 1098. Strains M2030 and 1098 precultured in SD medium (0.17% yeast nitrogen base without amino acids and ammonium sulfate (Becton Dickinson), 0.5% ammonium sulfate, and 2% glucose) were seeded in YNB medium (0.17% yeast nitrogen base without amino acids and ammonium sulfate, and 0.5% ammonium sulfate) containing 1% n-dodecane and cultured for 90 h. Since strain M2030 shows defects in the utilization of n-alkanes, as mentioned above, it exhibited poorer growth than strain 1098 in a medium containing n-dodecane as carbon source (data not shown). The expression of CmCDR1 was analyzed by northern blot analysis (Fig. 1) . A DNA probe to detect CmCDR1 specifically was designed with the nucleotide sequence of CmCDR1 and partial sequences of other CDR genes of C. maltosa, CmCDR1B, CmCDR1C, CmCDR1D, CmCDR3, and CmCDR4, which were obtained by colony hybridization (data not shown). The probe was amplified by PCR from the cloned CmCDR1 DNA with primers 5 0 -GGTT-GGGAATGTCCACAAAG-3 0 and 5 0 -CCGTTAACA-TTAGGTTGACC-3 0 , and radiolabeled with Random Primer DNA Labeling Kit ver. 2 (Takara Bio) and [-32 P] dCTP (Amersham). Signals were analyzed by Fujifilm FLA-3000 phosphor imager. In both strains, no transcripts of CmCDR1 were detected in the cells precultured in SD medium or in those at the early phase of culture on n-dodecane, but the amount of CmCDR1 transcript was much higher in strain M2030 at the later phase of culture, but not in strain 1098.
Next we analyzed to determine whether transcription of CmCDR1 would be upregulated by DCA added to the culture medium (Fig. 2) . Strains M2030 and 1098 were cultured in SD medium in the presence of DCAs of 10 to 20 carbons at concentrations of 1% for 2 h. In this culture condition, transcripts of CmCDR1 were detected in both strains, and their levels were highly increased in strain M2030 in the presence of longer carbon chain DCAs. More CmCDR1 transcripts were detected in strain M2030 as the length of the DCA increased from C14 to C18. These results imply that transcription of CmCDR1 was activated particularly in strain M2030 by the DCAs in the culture medium, although it is not clear whether the DCAs were sensed inside or outside the cells.
In C. albicans, transcription of CDR1 and CDR2, which encode ABC transporters involved in drug resistance, is induced by the addition of drugs. 24, 25) We analyzed to determine whether transcription of CmCDR1 would be upregulated by the addition of drugs (Fig. 3A) . Strains M2030 and 1098 were cultured in SD medium containing miconazole, cycloheximide, 4-nitoroquinoline 1-oxide, or ketoconazole for 1 h. Transcripts of CmCDR1 were significantly induced by cyclohex- Cultured in a Medium Containing n-Dodecane. Strains M2030 and 1098 precultured in SD medium were seeded into YNB medium containing 1% n-dodecane and cultured at 30 C. Total RNA was prepared 28) and subjected to Northern blot analysis for CmCDR1. Time 0 represents RNA from cells prior to culture in the medium containing n-dodecane. Ribosomal RNAs stained with ethidium bromide are shown as loading control. Due to the Addition of DCAs. Strains M2030 and 1098 were cultured at 30 C to the logarithmic growth phase in SD medium. DCAs of 10, 12, 14, 16, 18, and 20 carbons were added to a final concentration of 1%, and the cells were further incubated at 30 C for 2 h. Total RNA was extracted and subjected to Northern blot analysis for CmCDR1 expression. An ACT1-specific probe was used as internal standard. imide in both strains. In C. maltosa, transcription of a gene encoding an L41 ribosomal protein responsible for the inducible cycloheximide-resistant phenotype is activated by the addition of cycloheximide, and CGcn4p, a C. maltosa ortholog of transcription activator Gcn4p of S. cerevisiae, is involved in this activation, 26, 27) but the transcription activation of CmCDR1 by cycloheximide was observed in the deletion mutant of C-GCN4 of a C. maltosa strain of a different genetic background (data not shown), suggesting that the transcription of CmCDR1 is activated by a distinct mechanism in response to cycloheximide. Strain M2030 precultured in a medium containing n-dodecane for 80 h was more resistant to cycloheximide than strain 1098 (Fig. 3B) . Since a larger amount of CmCDR1 transcripts was detected in strain M2030 than in 1098 under these culture conditions (Fig. 1) , these results raise the possibility that CmCdr1p, the expression of which is induced by DCA produced in the n-dodecane-containing medium, confers cycloheximide resistance on strain M2030.
The results of this study suggest that CmCDR1 encodes an ABC transporter that is involved in the excretion of DCA and cycloheximide. We analyzed CmCDR1 from wild-type C. maltosa strain IAM12247, but the nucleotide sequences of CmCDR1 of strains M2030 and 1098 remain to be determined. It would be of interest to isolate and characterize CmCDR1 from strains M2030 and 1098, since strain M2030 might have obtained mutations in the promoter of CmCDR1 that increase its transcription or mutations in the ORF that potentiate the excretion of DCAs. In addition, our results suggest the possibility that the production of DCAs can be improved by overexpression of the genes encoding the transporters involved in the excretion of DCAs in C. maltosa and other DCA-producing yeasts.
